Innate Pharma SA
PAR:IPH
Innate Pharma SA
PAR:IPH
Price:
1.468
EUR
3.82%
Market Closed
Market Cap:
€137.6m
Wall Street
Price Targets
IPH Price Targets Summary
Innate Pharma SA
Innate Pharma SA
Wall Street analysts forecast IPH stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
IPH
is 6.273 EUR
with a low forecast of 6.161 EUR and a high forecast of 6.51 EUR.
Lowest
Price Target
6.161
EUR
320% Upside
Average
Price Target
6.273
EUR
327% Upside
Highest
Price Target
6.51
EUR
343% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IPH's stock price target?
Price Target
6.273
EUR
6.273
EUR
According to Wall Street analysts, the average 1-year price target for
IPH
is 6.273 EUR
with a low forecast of 6.161 EUR and a high forecast of 6.51 EUR.
What is Innate Pharma SA's Revenue forecast?
Projected CAGR
51%
51%
For the last 13 years the
compound annual growth rate for
Innate Pharma SA's revenue is
4%.
The projected
CAGR
for the next 4 years is
51%.
